Terms: = Uterine cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Diagnosis
27 results:
1. uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
2. Aggressive High-grade uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis.
Niu S; Rivera-Colon G; Lucas E
Int J Gynecol Pathol; 2023 Sep; 42(5):460-465. PubMed ID: 36811835
[TBL] [Abstract] [Full Text] [Related]
3. Molecular-Based Immunohistochemical Algorithm for uterine Leiomyosarcoma diagnosis.
Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
[TBL] [Abstract] [Full Text] [Related]
4. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and mdm2 Amplifications.
Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
[TBL] [Abstract] [Full Text] [Related]
5. A Case of Giant Mesenchymal uterine Tumor: Lipoleiomyoma.
Bosoteanu M; Vodă RI; Orasanu CI; Aschie M; Enciu M; Baltatescu GI
Am J Case Rep; 2022 Jan; 23():e934913. PubMed ID: 35042839
[TBL] [Abstract] [Full Text] [Related]
6. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the mdm2-P53 pathway.
Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
[TBL] [Abstract] [Full Text] [Related]
7. Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Lin DI; Killian JK; Venstrom JM; Ramkissoon SH; Ross JS; Elvin JA
Mod Pathol; 2021 May; 34(5):983-993. PubMed ID: 33077920
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
[TBL] [Abstract] [Full Text] [Related]
10. Retroperitoneal Well-Differentiated Liposarcoma With uterine-Type Leiomyomatous Differentiation: A First Case Report With Literature Analysis of Soft Tissue Sarcomas With Dual Lipomatous and Low-Grade Smooth Muscle Differentiation.
Tran TAN; de La Fuente S
Int J Surg Pathol; 2019 Oct; 27(7):798-803. PubMed ID: 31131653
[TBL] [Abstract] [Full Text] [Related]
11. P53 and Murine Double Mimute 2 (mdm2) Expression Changes and Significance in Different Types of Endometrial Lesions.
Jiang Z; Xu W; Dan G; Liu Y; Xiong J
Med Sci Monit; 2016 Dec; 22():4786-4793. PubMed ID: 27924072
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of mdm2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall.
Schoolmeester JK; Sciallis AP; Greipp PT; Hodge JC; Dal Cin P; Keeney GL; Nucci MR
Int J Gynecol Pathol; 2015 Nov; 34(6):576-83. PubMed ID: 26444253
[TBL] [Abstract] [Full Text] [Related]
13. Association of mdm2 and p53 polymorphisms with the advancement of cervical carcinoma.
Singhal P; Hussain S; Thakur N; Batra S; Salhan S; Bhambani S; Bharadwaj M
DNA Cell Biol; 2013 Jan; 32(1):19-27. PubMed ID: 23210739
[TBL] [Abstract] [Full Text] [Related]
14. SNP285C modulates oestrogen receptor/Sp1 binding to the mdm2 promoter and reduces the risk of endometrial but not prostatic cancer.
Knappskog S; Trovik J; Marcickiewicz J; Tingulstad S; Staff AC; ; Romundstad P; Hveem K; Vatten L; Salvesen HB; Lønning PE
Eur J Cancer; 2012 Sep; 48(13):1988-96. PubMed ID: 22119201
[TBL] [Abstract] [Full Text] [Related]
15. Large lipoleiomyoma of the uterine body.
Terada T
Ann Diagn Pathol; 2012 Aug; 16(4):302-5. PubMed ID: 21652245
[TBL] [Abstract] [Full Text] [Related]
16. Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature.
McDonald AG; Dal Cin P; Ganguly A; Campbell S; Imai Y; Rosenberg AE; Oliva E
Am J Surg Pathol; 2011 Feb; 35(2):221-7. PubMed ID: 21263242
[TBL] [Abstract] [Full Text] [Related]
17. mdm2 SNP309 is associated with endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):983-6. PubMed ID: 18398041
[TBL] [Abstract] [Full Text] [Related]
18. No association between SNP309 promoter polymorphism in the mdm2 and cervical cancer in a study from northeastern Brazil.
Meissner Rde V; Barbosa RN; Fernandes JV; Galvão TM; Galvão AF; Oliveira GH
Cancer Detect Prev; 2007; 31(5):371-4. PubMed ID: 18023538
[TBL] [Abstract] [Full Text] [Related]
19. Association between a functional single nucleotide polymorphism in the mdm2 gene and sporadic endometrial cancer risk.
Walsh CS; Miller CW; Karlan BY; Koeffler HP
Gynecol Oncol; 2007 Mar; 104(3):660-4. PubMed ID: 17123590
[TBL] [Abstract] [Full Text] [Related]
20. Aberrant cell cycle regulation in cervical carcinoma.
Kim YT; Zhao M
Yonsei Med J; 2005 Oct; 46(5):597-613. PubMed ID: 16259056
[TBL] [Abstract] [Full Text] [Related]
[Next]
